Elcar, 300 mg/ml 25 ml

Pharmacological action is metabolic. Participates in metabolic processes as a carrier of long-chain fatty acids (palmitic acid, etc.) from cytoplasm to mitochondria, where these acids undergo β-oxidation process with formation of adenosine triphosphoric acid and acetyl-CoA.
It improves protein and fat metabolism, increases secretion and enzymatic activity of gastric and intestinal juices, improves digestion, reduces excessive body weight and muscle fat content. It increases resistance to physical activity, inhibits ketoacid formation and anaerobic glycolysis, reduces lactacidosis, promotes economical use of glycogen and increases its reserves in the liver and muscles.
Anabolic and lipolytic effect. It normalizes elevated basal metabolism in hyperthyroidism: it is a peripheral (indirect) antagonist of thyroid hormones, rather than a direct inhibitor of thyroid function. It improves metabolism and tissue energy supply.< /p>

Indications

As part of complex therapy:

intense physical activity and psycho-emotional stress: to increase performance, endurance, reduce fatigue, incl. in elderly people;
during the rehabilitation period after illnesses and surgical interventions, injuries, incl. to accelerate tissue regeneration;
complex therapy of skin diseases (psoriasis, seborrheic eczema, focal scleroderma, discoid lupus erythematosus);
complex therapy of chronic gastritis with decreased secretory function and chronic pancreatitis with exocrine insufficiency;
mild hyperthyroidism;
neurological manifestations of brain lesions of vascular, toxic and traumatic origin;
anorexia nervosa syndrome;
diseases accompanied by a lack of carnitine or its increased loss (including myopathies, cardiomyopathies, mitochondrial diseases, hereditary diseases with concomitant mitochondrial deficiency) – to compensate for its deficiency as part of complex therapy.

In pediatric practice (treatment of children under 3 years of age under the supervision of a physician):

nursing premature babies and newborns who have suffered birth trauma or asphyxia;
children with a sluggish sucking reflex and low weight gain, decreased muscle tone, with insufficient development of motor and mental functions, as well as for the purpose of preventing these disorders in children at risk;
for stunted growth and underweight in children and adolescents under 16 years of age.

In adults in sports medicine and during intense training (during the training process when working on aerobic performance):

to improve speed-strength indicators and coordination of movements;
to increase muscle mass and reduce body fat mass;
for the prevention of post-training syndrome (acceleration of recovery processes after physical activity);
for traumatic injuries in order to accelerate muscle regeneration.

Pharmacological effect

Pharmacological action – metabolic. Participates in metabolic processes as a carrier of long-chain fatty acids (palmitic, etc.) from the cytoplasm to the mitochondria, where these acids undergo the process of β-oxidation with the formation of adenosine triphosphoric acid and acetyl-CoA.
Improves protein and fat metabolism, increases the secretion and enzymatic activity of gastric and intestinal juices, improves food absorption, reduces excess body weight and reduces fat content in muscles. Increases resistance to physical exercise, inhibits the formation of ketoacids and anaerobic glycolysis, reduces the degree of lactic acidosis, promotes economical consumption of glycogen and increases its reserves in the liver and muscles.
Has an anabolic and lipolytic effect. Normalizes increased basal metabolism in hyperthyroidism: it is a peripheral (indirect) antagonist of the action of thyroid hormones, and not a direct inhibitor of thyroid function. Improves metabolism and energy supply to tissues.

Special instructions

Children under 3 years of age should be treated under the supervision of a physician.
Influence on the ability to drive vehicles and operate machinery: the drug does not affect the performance of potentially hazardous activities that require special attention and quick reactions (driving a car and other vehicles, working with moving mechanisms, the work of a dispatcher and operator, etc.)

Active ingredient

Levocarnitine

Composition

Active ingredient: levocarnitine (carnifit) 300 mg.

Excipients: citric acid monohydrate 1.2 mg, methyl parahydroxybenzoate 0.5 mg, propyl parahydroxybenzoate 0.2 mg, purified water up to 1 ml.

Pregnancy

Use during pregnancy is contraindicated due to lack of research. It is necessary to stop breastfeeding while using the drug.

Contraindications

Individual intolerance to the components of the drug.

Side Effects

Possible: allergic reactions, gastralgia, dyspepsia, myasthenia gravis (in patients with uremia).

Interaction

Glucocorticosteroids promote the accumulation of the drug in tissues (except the liver), other anabolics enhance the effect.

Overdose

Symptoms: dyspeptic disorders, myasthenic disorders (in patients with uremia).
Treatment: gastric lavage, taking activated carbon.

Storage conditions

In a place protected from light, at a temperature not exceeding 25 °C

Shelf life

3 years

Manufacturer

Pik-Pharma, Russia